PubHive, an award-winning AI-powered SaaS platform for scientific literature and safety information management, announced the launch of its Generative AI Usage Dashboard, a pioneering tool designed to help pharmaceutical, biotech, MedTech, and broader life sciences companies adopt AI responsibly, with full compliance and operational clarity.
As Generative AI becomes increasingly integrated across pharmacovigilance, drug safety, medical and clinical affairs, knowledge management, and library functions, it is reshaping workflows related to literature automation, monitoring, extraction, review, and other safety-related processes. While this rapid adoption promises efficiency and innovation, it also poses challenges for organizational oversight and accountability. PubHive’s new dashboard addresses these concerns, offering teams actionable visibility and control over AI usage throughout their organizations.
Also Read: Salt AI Secures $10M to Shape Next Era of Contextual AI
“AI is transforming how life sciences teams work, but for leaders across compliance, pharmacovigilance, medical and clinical affairs, R&D, and knowledge management, the lack of visibility has been a major challenge,” said Raj Vaghela, President & CEO of PubHive. “With our new Generative AI Usage Dashboard, we’re giving organizations the oversight they need to innovate responsibly, control costs, and ensure every AI interaction aligns with regulatory and business priorities.”
Key Features of the Generative AI Usage Dashboard
-
User-Level Activity Tracking – Provides detailed insights into how individual team members interact with PubHive’s AI tools, ensuring accountability across departments.
-
Purpose-Wise Insights – Breaks down AI usage across functions such as AI-powered Search, Reference Q&A, Summarization, Insights, Auto Review, and other capabilities.
-
Cost Monitoring – Converts AI usage into clear financial metrics, helping operational leaders plan budgets and manage resources effectively.
-
Visual Compliance Reports – Offers intuitive dashboards and audit-ready reports for easier internal review and executive reporting.
Supporting Governance, Cost Control, and Transparency
The dashboard is engineered to meet three critical priorities for life sciences organizations:
-
Governance – Tracks every AI interaction to ensure it is measurable, documented, and auditable.
-
Cost Optimization – Provides usage-based analytics to monitor and manage AI-related expenses.
-
Transparency – Delivers clear dashboards and reports for operational, departmental, and executive oversight.
By addressing the needs of pharmacovigilance teams, compliance officers, clinical and medical affairs professionals, R&D leaders, and corporate librarians, the Generative AI Usage Dashboard transforms AI from a “black box” into a fully governed, reportable, and cost-efficient asset.
“Organizations want AI to deliver value, but they also need assurance that it’s being applied responsibly,” added Raj Vaghela. “This dashboard empowers them to strike that balance maximizing the benefits of AI while strengthening compliance, governance, and operational efficiency.”
The launch of the Generative AI Usage Dashboard reinforces PubHive’s commitment to purpose-driven AI adoption, supporting innovation while addressing the regulatory, compliance, and cost-efficiency requirements of modern life sciences companies.